Background Parenchymal Enhancement at Breast MR Imaging and Breast Cancer Risk

被引:280
|
作者
King, Valencia [1 ]
Brooks, Jennifer D. [2 ]
Bernstein, Jonine L. [2 ]
Reiner, Anne S. [2 ]
Pike, Malcolm C. [2 ]
Morris, Elizabeth A. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Radiol, Evelyn H Lauder Breast Ctr, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Evelyn H Lauder Breast Ctr, New York, NY 10065 USA
关键词
HORMONE REPLACEMENT THERAPY; CONTRAST-MEDIUM ENHANCEMENT; MAMMOGRAPHIC FEATURES; MENSTRUAL-CYCLE; TISSUE; DENSITY; WOMEN; PATTERNS; CLASSIFICATION; AGE;
D O I
10.1148/radiol.11102156
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To examine the relationships between breast cancer and both amount of fibroglandular tissue (FGT) and level of background parenchymal enhancement (BPE) at magnetic resonance (MR) imaging. Materials and Methods: A waiver of authorization was granted by the institutional review board for this retrospective HIPAA-compliant study. Among 1275 women who underwent breast MR imaging screening between December 2002 and February 2008, 39 breast carcinoma cases were identified. Two comparisons were performed: In one comparison, two normal controls-those of the women with negative (benign) findings at breast MR imaging-were matched to each breast cancer case on the basis of age and date of MR imaging. In the second comparison, one false-positive control-that of a woman with suspicious but nonmalignant findings at MR imaging-was similarly matched to each breast cancer case. Two readers independently rated the level of MR imaging-depicted BPE and the amount of MR imaging-depicted FGT by using a categorical scale: BPE was categorized as minimal, mild, moderate, or marked, and FGT was categorized as fatty, scattered, heterogeneously dense, or dense. Results: Compared with the odds ratio (OR) for a normal control, the OR for breast cancer increased significantly with increasing BPE: The ORs for moderate or marked BPE versus minimal or mild BPE were 10.1 (95% confidence interval [CI]: 2.9, 35.3; P < .001) and 3.3 (95% CI: 1.3, 8.3; P = .006) for readers 1 and 2, respectively. Similar odds were seen when the false-positive controls were compared with the breast cancer cases: The ORs for moderate or marked BPE versus minimal or mild BPE were 5.1 (95% CI: 1.4, 19.1; P = .005) and 3.7 (95% CI: 1.2, 11.2; P = .013) for readers 1 and 2, respectively. The breast cancer odds also increased with increasing FGT, but the BPE findings remained significant after adjustment for FGT. Conclusion: Increased BPE is strongly predictive of breast cancer odds. (C) RSNA, 2011
引用
收藏
页码:50 / 60
页数:11
相关论文
共 50 条
  • [21] Possible Breast Cancer Risk Related to Background Parenchymal Enhancement at Breast MRI: A Meta-Analysis Study
    Zhang, Hui
    Guo, Lili
    Tao, Weijing
    Zhang, Jiandong
    Zhu, Yan
    Abdelrahim, Mohamed E. A.
    Bai, Genji
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2021, 73 (08): : 1371 - 1377
  • [22] Prediction of background parenchymal enhancement on breast MRI using mammography, ultrasonography, and diffusion-weighted imaging
    Kawamura, Akiko
    Satake, Hiroko
    Ishigaki, Satoko
    Ikeda, Mitsuru
    Kimura, Reiko
    Shimamoto, Kazuhiro
    Naganawa, Shinji
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2015, 77 (03): : 425 - 437
  • [23] Background parenchymal enhancement and uptake as breast cancer imaging biomarkers: A state-of-the-art review
    Bauer, Ethan
    Levy, Miri Sklair
    Domachevsky, Liran
    Anaby, Debbie
    Nissan, Noam
    CLINICAL IMAGING, 2022, 83 : 41 - 50
  • [24] Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type
    Dilorenzo, Giuseppe
    Telegrafo, Michele
    La Forgia, Daniele
    Ianora, Amato Antonio Stabile
    Moschetta, Marco
    EUROPEAN JOURNAL OF RADIOLOGY, 2019, 113 : 148 - 152
  • [25] Background 99mTc-methoxyisobutylisonitrile uptake of breast-specific gamma imaging in relation to background parenchymal enhancement in magnetic resonance imaging
    Yoon, Hai-Jeon
    Kim, Yemi
    Lee, Jee Eun
    Kim, Bom Sahn
    EUROPEAN RADIOLOGY, 2015, 25 (01) : 32 - 40
  • [26] The association between breast cancer risk factors and background parenchymal enhancement at dynamic contrast-enhanced breast MRI
    Hellgren, Roxanna
    Saracco, Ariel
    Strand, Fredrik
    Eriksson, Mikael
    Sundbom, Ann
    Hall, Per
    Dickman, Paul W.
    ACTA RADIOLOGICA, 2020, 61 (12) : 1600 - 1607
  • [27] Quantitative assessment of background parenchymal enhancement is associated with lifetime breast cancer risk in screening MRI
    Yan, Ran
    Murakami, Wakana
    Mortazavi, Shabnam
    Yu, Tiffany
    Chu, Fang-I.
    Lee-Felker, Stephanie
    Sung, Kyunghyun
    EUROPEAN RADIOLOGY, 2024, 34 (10) : 6358 - 6368
  • [28] Background Parenchymal Enhancement at Postoperative Surveillance Breast MRI: Association with Future Second Breast Cancer Risk
    Lee, Su Hyun
    Jang, Myoung-jin
    Yoen, Heera
    Lee, Youkyoung
    Kim, Yeon Soo
    Park, Ah Reum
    Ha, Su Min
    Kim, Soo-Yeon
    Chang, Jung Min
    Cho, Nariya
    Moon, Woo Kyung
    RADIOLOGY, 2023, 306 (01) : 90 - 99
  • [29] Screening Breast MRI and the Science of Premenopausal Background Parenchymal Enhancement
    Vong, Stephen
    Ronco, Anthony J.
    Najafpour, Elham
    Aminololama-Shakeri, Shadi
    JOURNAL OF BREAST IMAGING, 2021, 3 (04) : 407 - 415
  • [30] Evaluation of association between degree of background parenchymal enhancement on MRI and breast cancer subtype
    Ha, Richard
    Mango, Victoria
    Al-Khalili, Rend
    Mema, Eralda
    Friedlander, Lauren
    Desperito, Elise
    Wynn, Ralph T.
    CLINICAL IMAGING, 2018, 51 : 307 - 310